As they described in Radiology Case Reports, the patient noted that she had been having increasing weakness in her left arm ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

What is Parkinsonism? Parkinsonism is a neurological disorder that affects the movement of the body. It is named after James ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

The researchers suggest clinicians might tailor their approach to account for Asian Americans' younger average age when they ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in ...

Commissions do not affect our editors' opinions or evaluations. In every case, is applying for multiple cards at the same time a good idea? Are there advantages to doing this? How will it affect ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved Ocrevus IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis ...